Your cart is currently empty!
The U.S. Food and Drug Administration is reviewing a cutting-edge therapy called exa-cel that could potentially cure people of sickle cell disease, a painful and deadly disease with no universally successful treatment. “If approved, exa-cel, made by Boston-based Vertex Pharmaceuticals and the Swiss …
The U.S. Food and Drug Administration is reviewing a cutting-edge therapy called exa-cel that could potentially cure people of sickle cell disease, a painful and deadly disease with no universally successful treatment. “If approved, exa-cel, made by Boston-based Vertex Pharmaceuticals and the Swiss … Read More
